CVS News and Press, CVS Health Corporation From 03/05/24

2024-03-05 14:30:06 ET CVS Health Corporation (CVS) 45th Annual Raymond James Institutional Investors Conference Transcript March 5, 2024, 9:50 AM ET Executives Tom Cowhey - Executive Vice President and CFO Analysts Presentation Unidentified Analyst...

2024-03-02 11:16:00 ET One ratio that gets a lot of attention (and rightfully so) from investors is a stock's payout ratio. It tells them how much of a company's earnings are paid out in the form of dividends. Generally, the higher the ratio is, the more unsustainable the dividend is. ...

2024-02-26 01:44:56 ET Summary Bridgewater Associates' 13F portfolio value increased from ~$16.55B to ~$17.86B in Q4 2023. The top three individual stock positions are Procter & Gamble, Coca-Cola, and Costco. Stake increases include iShares Core S&P 500 ETF, Johnson &a...

2024-02-23 03:26:37 ET Summary Liberty All-Star Equity CEF offers a high distribution yield and a total return nearing 200% over the last 5 years. The fund's portfolio is diverse, with a focus on US equity markets. The fund has exposure to top-tier companies like Microsoft, NVIDIA...

CVS Health to participate at the 45nd Annual Raymond James Institutional Investors Conference PR Newswire WOONSOCKET, R.I. , Feb. 21, 2024 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced that Executive Vice President and Chief Financial Officer Tom Cowhe...

2024-02-18 12:00:00 ET More on Medtronic Medtronic Is A Healthy Portfolio Boost Medtronic: A Good Choice For Dividend Investors Seeking For Low Volatility Medtronic: Hugo's Global Rollout Is Positive; GLP-1 Is Negative Anti-obesity meds can expand the market ...

2024-02-16 21:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-02-15 06:25:36 ET Summary CVS reported mixed Q4 and FY23 earnings, exceeding the top line but missing margins on the back of elevated medical costs, with Q4 MLR at 88.5%. Despite the cost pressure in insurance, pricing measured by $/member growth has shown continued strong re...

2024-02-14 18:00:17 ET Billionaire Larry Robbins' Glenview Capital Management took new positions in semiconductor firm Marvell Technology ( NASDAQ: MRVL ) and managed care player CVS Health ( CVS ) in Q4 2023, while exiting its stake in Microsoft ( NASDAQ: MSFT ) and cut...

2024-02-14 16:14:33 ET More on Apple, Akamai, etc. Coca-Cola: Do Not Buy The Likely February Dividend Hike Akamai Technologies, Inc. (AKAM) Q4 2023 Earnings Call Transcript The Coca-Cola Company (KO) Q4 2023 Earnings Call Transcript Apple's benefit from Andro...